Bed Bath & Beyond Inc. (NASDAQ:BBBY) issued its earnings results on Wednesday. The retailer reported $1.11 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.67 by $0.56. Bed Bath & Beyond had a net margin of 6.66% and a return on equity of 31.15%. The firm earned $2.99 billion during the quarter, compared to the consensus estimate of $901.50 million. During the same period in the previous year, the company posted $1.21 EPS. The firm’s revenue for the quarter was down .2% on a year-over-year basis.
Bed Bath & Beyond (NASDAQ:BBBY) traded up 0.14% during midday trading on Wednesday, reaching $43.11. 3,329,123 shares of the company traded hands. The stock’s 50 day moving average is $44.93 and its 200 day moving average is $45.70. Bed Bath & Beyond has a one year low of $41.15 and a one year high of $61.90. The company has a market capitalization of $6.51 billion, a price-to-earnings ratio of 8.60 and a beta of 0.72.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 17th. Investors of record on Friday, December 16th will be given a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a yield of 1.16%. Bed Bath & Beyond’s dividend payout ratio is presently 9.98%.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/bed-bath-beyond-inc-bbby-releases-quarterly-earnings-results-misses-estimates-by-0-56-eps.html
In other Bed Bath & Beyond news, COO Eugene A. Castagna sold 17,866 shares of the company’s stock in a transaction dated Friday, August 12th. The shares were sold at an average price of $45.86, for a total transaction of $819,334.76. Following the sale, the chief operating officer now directly owns 140,630 shares of the company’s stock, valued at $6,449,291.80. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 4.70% of the company’s stock.
A number of large investors have recently added to or reduced their stakes in the stock. FMR LLC increased its stake in Bed Bath & Beyond by 7.6% in the second quarter. FMR LLC now owns 12,156,947 shares of the retailer’s stock valued at $525,423,000 after buying an additional 860,235 shares during the period. BlackRock Group LTD boosted its stake in shares of Bed Bath & Beyond by 12.1% in the second quarter. BlackRock Group LTD now owns 1,896,021 shares of the retailer’s stock valued at $81,945,000 after buying an additional 205,277 shares in the last quarter. APG Asset Management N.V. boosted its stake in shares of Bed Bath & Beyond by 20.1% in the second quarter. APG Asset Management N.V. now owns 937,554 shares of the retailer’s stock valued at $40,521,000 after buying an additional 157,200 shares in the last quarter. Parametric Portfolio Associates LLC boosted its stake in shares of Bed Bath & Beyond by 14.7% in the second quarter. Parametric Portfolio Associates LLC now owns 654,963 shares of the retailer’s stock valued at $28,308,000 after buying an additional 83,734 shares in the last quarter. Finally, Guggenheim Capital LLC boosted its stake in shares of Bed Bath & Beyond by 20.4% in the second quarter. Guggenheim Capital LLC now owns 616,866 shares of the retailer’s stock valued at $26,662,000 after buying an additional 104,670 shares in the last quarter. 95.16% of the stock is currently owned by institutional investors and hedge funds.
Several equities research analysts have commented on the stock. Vetr raised shares of Bed Bath & Beyond from a “buy” rating to a “strong-buy” rating in a research note on Thursday, August 25th. Zacks Investment Research raised shares of Bed Bath & Beyond from a “sell” rating to a “hold” rating in a research report on Wednesday, August 17th. Wedbush reissued a “neutral” rating and set a $42.00 price objective on shares of Bed Bath & Beyond in a research report on Tuesday, August 2nd. BTIG Research began coverage on shares of Bed Bath & Beyond in a research report on Wednesday, June 1st. They set a “neutral” rating for the company. Finally, Credit Suisse Group AG began coverage on shares of Bed Bath & Beyond in a research report on Monday, July 18th. They set a “neutral” rating and a $41.00 price objective for the company. Eight equities research analysts have rated the stock with a sell rating, nineteen have given a hold rating, two have given a buy rating and two have issued a strong buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $50.20.
About Bed Bath & Beyond
Bed Bath & Beyond Inc is a retailer, which operates under the names Bed Bath & Beyond (BBB), Christmas Tree Shops, Christmas Tree Shops andThat! or andThat! (collectively, CTS), Harmon or Harmon Face Values (collectively, Harmon), buybuy BABY (Baby) and World Market, Cost Plus World Market or Cost Plus (collectively, Cost Plus World Market).
Receive News & Ratings for Bed Bath & Beyond Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bed Bath & Beyond Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.